Alexander Tamalunas
Papers
2
Total Citations
10
H-Index
2
About
Dr. Alexander Tamalunas is a urologic oncologist whose research focuses on advancing minimally invasive and non-invasive treatment strategies for renal cell carcinoma (RCC). His major contributions center on the use of robotic radiosurgery (RRS) as an alternative to traditional surgical approaches, particularly for patients who are not ideal candidates for invasive procedures. In his most-cited work, a 2022 propensity score-matched analysis (8 citations), Dr. Tamalunas demonstrated that single-fraction RRS achieves comparable oncological outcomes to open partial nephrectomy, with no significant difference in overall survival (p=0.459) and a favorable safety profile. This study provides critical evidence supporting RRS as a viable, less invasive option for select RCC patients. His 2021 analysis (2 citations) further expands the application of RRS, assessing its safety and efficacy for treating visceral and lymph node metastases, highlighting its potential in managing advanced disease alongside systemic therapies. Dr. Tamalunas’s work is notable for bridging the gap between surgical oncology and radiation oncology, offering patients a non-invasive alternative that preserves renal function and reduces recovery time. His research continues to shape the paradigm of personalized, organ-sparing treatment in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2